EBM TechnologiesROCO:8409 64 Gross Margin % is 82.23% as of Dec. 2025, which is 22% above its 10-year median of 67.48. GuruFocus rates ROCO:8409 with a GF Score™ of 64/100 and a GF Value™ of NT$25.74 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 629 Healthcare Providers & Services companies, EBM Technologies ranks better than 78.22% on this metric.
The historical rank and industry rank for EBM Technologies's Gross Margin % or its related term are showing as below:
ROCO:8409'
s Gross Margin % Range Over the Past 10 Years
Min: 48.04 Med: 67.48 Max: 77.86
Current: 68.89
During the past 13 years, the highestGross Margin % of EBM Technologies was 77.86%. The lowest was 48.04%. And the median was 67.48%.
ROCO:8409's Gross Margin % is ranked better than 78.22% of 629
companies
in the Healthcare Providers & Services industry
Industry Median: 40.06
vs ROCO:8409: 68.89
EBM Technologies had a gross margin of 82.23% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for EBM Technologies was 1.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
EBM Technologies had a gross margin of 82.23% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
EBM Technologies Gross Margin % Related Terms
EBM Technologies Gross Margin % Historical Data
* Premium members only.
The historical data trend for EBM Technologies's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:8409 vs VEEV, BTSG, TEM: Gross Margin % Comparison
For the Health Information Services subindustry, EBM Technologies's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EBM Technologies Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EBM Technologies's Gross Margin % distribution charts can be found below:
* The bar in red indicates where EBM Technologies's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
EBM Technologies (ROCO:8409) has a Gross Margin % of 82.23% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on EBM Technologies and its competitors. This is 22% above median its historical median of 67.48. Over the past decade, EBM Technologies' Gross Margin % has ranged from 48.04 to 77.86. According to the industry distribution chart, EBM Technologies ranks #137 out of 629 companies in the Healthcare Providers & Services industry, placing it in the top 21.8%.
Is EBM Technologies' Gross Margin % too high?
EBM Technologies' current Gross Margin % of 82.23% is 22% above median its 10-year median of 67.48. Over the past 10 years, this metric has ranged from a low of 48.04 to a high of 77.86. The Healthcare Providers & Services industry median Gross Margin % is 40.06. EBM Technologies' value of 82.23% is 105.3% above this industry median. Based on the distribution chart, EBM Technologies ranks #137 out of 629 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, EBM Technologies has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EBM Technologies' Gross Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, EBM Technologies ranks #137 out of 629 companies for Gross Margin %. This places EBM Technologies in the top 22% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 40.06. EBM Technologies' value of 82.23% is 105.3% above this benchmark. Historically, EBM Technologies' own Gross Margin % has ranged from 48.04 to 77.86 over the past decade. While the company's 10-year median is 67.48 vs. the industry median of 40.06, EBM Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.06, based on 629 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EBM Technologies's current Gross Margin % of 82.23% is 105.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on EBM Technologies and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EBM Technologies's current Gross Margin % is 82.23%, which is 22% above median its own 10-year median of 67.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EBM Technologies stock overvalued right now?
Based on GuruFocus' analysis, EBM Technologies (ROCO:8409) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$25.74, compared to a current price of NT$19.10 — trading 25.8% below its estimated fair value. The current Gross Margin % is 82.23%, which is 22% above median its 10-year median of 67.48 and 105.3% above the Healthcare Providers & Services industry median of 40.06. EBM Technologies' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For EBM Technologies (ROCO:8409), the current Gross Margin % is 82.23% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EBM Technologies (ROCO:8409) Overvalued in 2026?
Based on GuruFocus' analysis, EBM Technologies stock appears to be undervalued.
The current stock price of NT$19.10 is trading 25.8% below its estimated GF Value™ of NT$25.74.
GuruFocus considers EBM Technologies to be Modestly Undervalued.
Key valuation signals for ROCO:8409:
Gross Margin %: 82.23% (22% above median its 10-year median of 67.48)
GF Value™: NT$25.74 vs. price of NT$19.10 (25.8% below fair value)
Industry Position: 105.3% above the Healthcare Providers & Services median (#137 of 629)
No single metric tells the full story. See the ROCO:8409 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EBM Technologies Inc is engaged in picture archiving and communication systems. Its products include EBM diagnostic and reviewing station, EBM storage and utility server, and EBM breast imaging for PACS. The company develops and markets medical information technology solutions; and provides to the health sector.
64GF Score
Get the complete analysis for ROCO:8409
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:8409 has been successfully added to your 
